Navneet Majhail

Navneet's Light The Night Fundraiser Light The Night At Blood Cancer United's, formerly LLS, Light The Night we gather as a community to celebrate, honor, and remember those touched by blood cancers. Friends, families, schools, corporate...

I am walking at Blood Cancer United Nashville's Light The Night Walk on October 23rd. I will be walking for our patients who are an inspiration to me and our team at Sarah Cannon Cancer Network Transplant and Cellular Therapy Program at TriStar Centennial.

pages.lls.org/ltn/tn/MidTN...

Navneet's Light The Night Fundraiser Light The Night At Blood Cancer United's, formerly LLS, Light The Night we gather as a community to celebrate, honor, and remember those touched by blood cancers. Friends, families, schools, corporate...

I am walking at Blood Cancer United Nashville's Light The Night Walk on October 23rd. I will be walking for our patients who are an inspiration to me and our team at Sarah Cannon Cancer Network Transplant and Cellular Therapy Program at TriStar Centennial.

pages.lls.org/ltn/tn/MidTN...

It was great to catch up with fellow Cleveland Clinic expat Nate Pennell during his recent visit to Sarah Cannon Research Institute Nashville. Looking forward to his leadership and vision for cancer at BMS.

Impactful @ascocancer.bsky.social @theaacr.bsky.social session on innovations and access challenges for gene therapy. Dr Frangoul from Sarah Cannon Cancer Network/SCRI shared experience with clinical trials of Exa-cel. Jimi Olaghere shared experience as patient #16 on a trial. #ASCO25

@daxmd.bsky.social presents on multi-cancer early detection at #ASCO25: Highlights positive predictive value & sensitivity of reflex ctDNA methylation MCED for several cancer types in individuals with obesity. With its footprint in 20 states, Sarah Cannon Cancer Network is a pioneer in MCED studies.

Grateful for Sarah Cannon Research Institute colleagues all over the country who work hard and collaborate to advance cancer therapeutics. Learn more about #SCRI research that is being presented at #ASCO25 #ASCO2025 www.scri.com/asco/

👋 or 👍 if you are attending #ASCO25

Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation @bloodadvances.bsky.social

ashpublications.org/bloodadvance...

I am in profound awe of the closeted prostate cancer experts who have emerged on social media over the last 24-48 hrs!

Congratulations to Malini and you #ProudDad!

Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure | NEJM Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment of B-cell cancers, but many patients do not have long-term remission. We designed an anti-CD19 enhanced (armore...

Hey regular CAR-T 🚗 , armored #CARTcell 🏎️ has entered the room!
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure | New England Journal of Medicine www.nejm.org/doi/full/10....

Applications are open for the 2026 International Trainee Observership Program. One international trainee from a low/mid-income country will participate in 4-week-long observership at the @uofcahealth.bsky.social.

📆 Deadline to apply: Friday, June 13
ow.ly/Ih0650VK0vn #MedSky #HCT #celltherapy

a picture of yoda from star wars with the words `` may the fourth be with you '' written on it . ALT: a picture of yoda from star wars with the words `` may the fourth be with you '' written on it .

Happy #StarWarsDay

#MayThe4thBeWithYou

Congrats to Dr Stephen Strickland from Sarah Cannon Research Institute at TriStar Centennial Medical Center, Nashville for presenting first-in-human results of SENTI-202 (CD33/FLT3 off-the-shelf CAR NK #celltherapy) in heme malignancies/AML #AACR25
www.aacr.org/about-the-aa...

Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an immunotherapy trial offered stunning results.

Medicine Spares Cancer Patients From Grisly Surgeries and Harsh Therapies www.nytimes.com/2025/04/27/h...

🙏 for sharing @jameabraham.bsky.social - we share our learnings from Sarah Cannon Transplant and Cellular Therapy Network outpatient #CARTcell program (200+ patients treated in 2024)

Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy Until recently, measles exposures were relatively rare and so, consequently, were an afterthought for cancer patients and/or blood and marrow transplant recipients and their providers. Declines in mea...

Getting a lot of questions from our immunocompromised transplant/#CARTcell patients about measles vaccination with the recent uptick in outbreaks across the US; Resurfacing 2019 @astct.bsky.social guideline by @pergamic.bsky.social and colleagues www.astctjournal.org/article/S108...

That is a 50% success rate - pretty high for academic medicine! 😀

Had a great 1 1/2 days with new/emerging transplant and cellular therapy leaders at @astct.bsky.social Leadership Course; future of transplant and cell therapy is strong in the hands of our very talented young physician and administrative leaders

Foundation for the Accreditation of Cellular Therapy is organizing a community #CART working group to facilitate broader utilization of its accreditation standards for cell therapies - important step towards providing high-quality care to patients in the community factglobal.org/education-an...

An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last | JCO Oncology Practice

Dr David Johnson reprises 7 dictums for oncologists on what NOT to do for grand rounds:
- Microscopic mayhem
- TNM torture
- Mechanism of action meltdown
- Dosage deadlock
- Criteria catatonia
- Kaplan Meier killer
- Lymph node lobotomy
@ascocancer.bsky.social JOP ascopubs.org/doi/10.1200/...

Academic Writing: Who is the Audience and What is the Message? “The Secret is Comprised in Three Words–Work, Finish, Publish”Michael Faraday

Academic Writing: Who is the Audience and What is the Message? Dr Weisdorf challenges us to consider: Which papers stated something new? Which challenged existing dogma or changed the field? Which were really important over time? @astct.bsky.social www.astctjournal.org/article/S266...

Congratulations Gunjan (PS: @drmiguelperales.bsky.social have her join @bsky.app 🙏)

Huge loss for the cell and gene therapy community. Dr Marks had been at the forefront of innovating US’s regulatory framework to ensure access to these transformative therapies.

Is that 1/10 centers that already offer cell therapy? We onboard new CART companies and products all the time - would love to hear what the discussion was around why centers who can do this are not getting on board with the TCR product for synovial sarcoma.

Comparative Efficacy of Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion before Chimeric Antigen Receptor T-Cell Therapy in Lymphoma Chimeric antigen receptor T-cell (CAR-T) therapy is a widely adopted treatment for relapsed/refractory non-Hodgkin lymphomas (NHLs)1. FDA-approved CAR-T products for large B-cell lymphoma (LBCL) inclu...

Sarah Cannon Transplant and Cellular Therapy Registry work led by Drs Rao and Battiwalla comparing bendamustine vs. Flu/Cy LD chemo prior to #CART in #Lymphoma. This was done during period of Flu shortage. No difference in OS, PFS, CRS, ICANS.
www.astctjournal.org/article/S266...

Congratulations to Kiran. Very nicely done.

Nephrotoxicity in CAR-T cell therapy Modern immunotherapies revolutionize cancer treatment. Due to advances in molecular biology, therapies such as immune checkpoint inhibitors, naked, armed, and bispecific monoclonal antibodies, and chi...

Nephrotoxicity in CAR-T cell therapy - Transplantation and Cellular Therapy @astct.bsky.social www.astctjournal.org/article/S266...

Best Practices in Gene Therapy for Sickle Cell Disease and Transfusion-dependent β-Thalassemia Sickle cell disease (SCD) and transfusion-dependent β-thalassemia (TDT) are inherited blood disorders caused by pathogenic variants of the β-globin ge…

How to do gene therapy for sickle cell disease and thalassemia - from Dr Frangoul et al at our pediatric Sarah Cannon TCT Program at TriStar Centennial in Nashville. #GeneTherapy #SickleCell @astct.bsky.social

www.sciencedirect.com/science/arti...

Guinness 0.0: a miracle! - Bone Marrow Transplantation Bone Marrow Transplantation - Guinness 0.0: a miracle!

Beer, wine, and transplant. I have always enjoyed these reflections from Dr McCann in Bone Marrow Transplant. www.nature.com/articles/s41...